• HealthBeacon Plans Pill Adherence Tool

    HealthBeacon Plans Pill Adherence Tool
    By Marcus A. BanksFrom reducing the guesswork around specialty drug coverage to identifying reg flags for oral and injectable medication noncompliance, a new generation of pharmacy technologies showcased at Asembia’s AXS26 Summit, in Las Vegas, promises practical solutions to some of specialty pharmacy’s most persistent challenges.This year, Irish health tech company HealthBeacon—a subsidiary of Hamilton Beach Health—plans to launch a device to improve medication adherence for pills. The
  • Nutritional Challenges in Neurodegenerative Diseases

    Nutritional Challenges in Neurodegenerative Diseases
    By Gina ShawDespite being distinct diseases, amyotrophic lateral sclerosis (ALS), Parkinson’s, and dementia share a largely common set of nutritional challenges: self-feeding difficulty, gastrointestinal symptoms, dysphagia, medication interactions, feeding tube considerations, and energy expenditure abnormalities. Unfortunately, there is a lack of hard evidence that practitioners can turn to when managing the nutritional needs of patients with these complex neurodegenerative diseases, experts
  • Pemgarda Pre-Exposure Prophylaxis Appears Safe and Effective in Advanced HIV, Blood Cancers

    Pemgarda Pre-Exposure Prophylaxis Appears Safe and Effective in Advanced HIV, Blood Cancers
    Originally published by our sister publication Infectious Disease Special EditionBy Jenny Blair, MD, MS Michael Mina, MD, PhDTwo studies of the anti-SARS-CoV-2 monoclonal antibody pemivibart (Pemgarda, Invivyd) suggest it is safe and effective for pre-exposure prophylaxis (PrEP) among patients with advanced HIV or hematologic malignancies.“For individuals who can’t mount an immune response, this can be a life-saving drug,” said Michael Mina, MD, PhD, the chief medical officer and chief epi
  • Extending BCMA Into the OR Tests Workflow—and Culture

    Extending BCMA Into the OR Tests Workflow—and Culture
    By Gina ShawBringing barcode medication administration (BCMA) into ORs remains one of medication safety’s most persistent challenges, but one that is increasingly achievable with the right preparation, multidisciplinary buy-in, and workflow flexibility, according to presenters at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas. The experiences of several health systems demonstrate how perioperative care teams are tackling the logistical barriers to close the gap in BCMA a
  • Advertisement

  • Preparing for America’s Next Top (Drug) Models

    Preparing for America’s Next Top (Drug) Models
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Celt Studio, sherryvsmith - stock.adobe.comBy Gina ShawFederal drug pricin
  • More HPV Doses Are Associated With Lower Cervical Cancer Incidence

    More HPV Doses Are Associated With Lower Cervical Cancer Incidence
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksTwo or three HPV vaccine doses are associated with a lower incidence of cervical cancer than one dose, according to a retrospective analysis from the West Virginia University (WVU) School of Pharmacy. The analysis earned a platinum abstract award at AMCP Nexus 2026, in San Diego.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure
  • A String of Practice Pearls on AI, Better Labeling, and Naloxone

    A String of Practice Pearls on AI, Better Labeling, and Naloxone
    By Karen BlumThree pharmacy initiatives show how practical changes can strengthen medication safety and patient care: an in-house artificial intelligence model that helps identify medication errors in voluntary reports; redesigned labels that reduce reliance on auxiliary stickers; and an emergency department program that puts take-home naloxone kits within reach of patients at risk for overdose.1AI Models Can Help Review Med Safety EventsAn in-house developed AI model can help pharmacists and th
  • NASP Survey: Trust, Communication With Pharmacists Key Patient Satisfiers

    NASP Survey: Trust, Communication With Pharmacists Key Patient Satisfiers
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Karen BlumCommunication with the specialty pharmacy team, trust and confidence in the pharmacists or nurses, and refill access and delivery timeliness are key drivers of patient satisfaction, according to the National Association of Specialty Pharmacy’s (NASP’s) 2025 Patient Satisfaction Survey.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }f
  • Advertisement

  • Proactive Copay Savings Linked to Better Adherence in 2 Health Plan Studies

    Proactive Copay Savings Linked to Better Adherence in 2 Health Plan Studies
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Credit ©McMahon GroupBy Gina ShawHealth plans that offer members point-of
  • Managed Care AI Is Outpacing Governance, Pharmacy Experts Warn

    Managed Care AI Is Outpacing Governance, Pharmacy Experts Warn
    Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McMahon GroupBy Gina ShawHealth plans and pharmacy benefit managers unde
  • Beyond the Error: Recognizing And Addressing Second Victim Syndrome

    Beyond the Error: Recognizing And Addressing Second Victim Syndrome
    Jennifer Phillips, PharmD, BCPSUIC Retzky College of PharmacyDrug Information GroupChicago, IllinoisBonnie Bachenheimer, PharmD, BCPSAdvocate Health Department of PharmacyDrug Policy CenterChicago, IllinoisThe term “second victim” was first coined by Albert Wu, MD, in a 2000 editorial, where he discussed the profound psychological impact that a medical error can have on practicing clinicians and the need for a culture and systems that support affected individuals.1A 2013 systematic review id
  • Manufacturer Claims Data Demands Put 340B Pricing at Risk as Rebate Pilot Nears

    Manufacturer Claims Data Demands Put 340B Pricing at Risk as Rebate Pilot Nears
    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }©McMahon GroupBy Gina ShawDrug manufacturers have begun enforcing their 340B claims data policies, moving pharmacies with unvalidated purchases into
  • Highlights in HD Testing, Patient Monitoring, and Inventory Management

    Highlights in HD Testing, Patient Monitoring, and Inventory Management
    By Marcus A. BanksThe ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas, featured technologies to improve hazardous drug sampling, enhance real-time response to patient emergencies, and provide more customized high-density storage.BD, ChemoGLO Streamline Hazardous Drug TestingBD and ChemoGLO now offer streamlined hazardous drug detection that only requires one wipe sample per location for all analyses, rather than having to use different collection kits and wiping side by side.Th
  • EDSA Pilot Elevates Supply Chain Transparency

    EDSA Pilot Elevates Supply Chain Transparency
    By Gina ShawApril GilesA first-of-its-kind supply chain transparency initiative has demonstrated that hospitals, distributors, and other stakeholders can share sensitive inventory data across organizational boundaries—and that doing so creates real planning value even when no drug shortage is underway.The Drug Resiliency & Transparency Pilot, led by the End Drug Shortages Alliance (EDSA), emerged from an August 2024 White House roundtable under the Cancer Moonshot initiative that focused o
  • IV Workflow Management Systems Keep Pace With Expanding Ambulatory Infusion Market

    IV Workflow Management Systems Keep Pace  With Expanding Ambulatory Infusion Market
    By Gina ShawIV workflow management systems (IVWMS) have long been a fixture of inpatient sterile compounding, and their footprint is expanding rapidly. Health systems are now pushing these platforms into ambulatory infusion centers, 503B outsourcing facilities, and home infusion pharmacies, each of which carries its own safety demands, regulatory requirements, and operational constraints.“This is encouraging,” said Mark Neuenschwander, the founding director of the THRIV Coalition for IV Accu
  • The Value Case for Outpatient ID Pharmacy

    By Gina ShawTodd Sorensen, PharmDWhen Todd Sorensen, PharmD, asked a room of infectious disease pharmacists at the newly combined Making a Difference in Infectious Diseases and Society of Infectious Disease Pharmacists 2026 meeting, in Orlando, Florida, how many were actively billing fee-for-service for their cognitive work, not a single hand went up. The same question in the previous session had yielded the same answer: none.Dr. Sorensen, the senior executive associate dean for strategic initia
  • ACHC Opens Simulated Cleanroom Suite for Hands-on Sterile Compounding Training

    ACHC Opens Simulated Cleanroom Suite for Hands-on Sterile Compounding Training
    By Gina ShawThe Accreditation Commission for Health Care (ACHC) has opened a fully functioning simulated cleanroom suite at its new headquarters in Cary, North Carolina, giving pharmacists and pharmacy technicians a place to practice and validate sterile compounding technique under USP General Chapter <797> and <800> conditions in a near-identical environment to a working pharmacy, without interrupting operations or creating any potential patient care issues.The facility, managed by
  • PN Use Survey Finds Continued Room for Improvement

    PN Use Survey Finds Continued Room for Improvement
    By Karen BlumThe 2025 ASPEN Parenteral Nutrition (PN) Use Survey identified several encouraging trends, including a major shift toward multidisciplinary care, along with a few areas of concern, such as lagging use of standardized order forms that boost patient safety and macronutrient regimens that fall short of treatment guidelines.The quantitative cross-sectional survey of 1,160 clinicians was designed to address multiple steps in the PN use process and updates previous surveys from 2011 and 2
  • Expert Strategies for Surviving IVWMS Downtimes

    Expert Strategies for Surviving IVWMS Downtimes
    By Gina ShawWhen an IV workflow management system (IVWMS) goes down, staff accustomed to relying on it must switch to manual procedures, often under pressure. Those skills can fade without practice, two sterile compounding experts told attendees at NHIA26, in Denver.“Training staff in manual processes is essential, and you need redundancy in place wherever possible, especially for equipment such as ACDs [automated compounding devices] and compounding pumps,” said Glen Gard, CPhT-Adv, CSPT, a
  • First mRNA Flu Vaccine Puts Pharmacists on Counseling Front Line

    First mRNA Flu Vaccine Puts Pharmacists on Counseling Front Line
    By Fran KritzThe FDA’s approval of the first mRNA influenza vaccine, Moderna’s mRNA-1010 (mFlusiva), is likely to prompt questions from patients and clinicians, and pharmacists should be prepared to answer them.Moderna said it plans to deliver supplies “to select retailers” in time for the 2026-2027 flu season, which typically begins in October.“When there’s a new vaccine, people are often unsure about whether it works and what their experience will be,” said Brigid Groves, PharmD,
  • AI Helpful in Patient Care, but Always Check Its Outputs

    AI Helpful in Patient Care, but Always Check Its Outputs
    By Karen BlumArtificial intelligence can help with several administrative and clinical tasks in patient care, but clinicians are still needed to review, vet, and build on the responses generated by AI tools, speakers said during the ASPEN 2026 Nutrition Science & Practice Conference, in Long Beach, California.Summaries, Drafting, and DocumentationOn the administrative side, AI tools can be used to review and summarize emails and help draft responses, or to sort emails into categories and fla
  • FDA Compounding Panel Backs 6 of 7 Peptides Despite Safety Risks in Oversight and Production

    FDA Compounding Panel Backs 6 of 7 Peptides Despite Safety Risks in Oversight and Production
    By Gina Shaw Rita Jew, PharmDThe FDA Pharmacy Compounding Advisory Committee’s (PCAC’s) recommendation that six of seven peptides be added to the 503A bulk drug substances list has alarmed leading medication safety experts.The move departs from the evidence-based process the agency normally follows and leaves several unresolved safety questions in place, noted Rita Jew, PharmD, the president of the Institute for Safe Medication Practices (ISMP), part of ECRI. Demand for peptide produ
  • FDA Approves Zilucoplan Once-Daily Autoinjector for Generalized Myasthenia Gravis

    FDA Approves Zilucoplan Once-Daily Autoinjector for Generalized Myasthenia Gravis
    By PPN StaffThe FDA has approved zilucoplan (Zilbrysq, UCB) for the treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor antibody–positive.Zilucoplan is the first self-administered, once-daily autoinjector administration option for this form of gMG. The autoinjector is designed to automatically deliver a predetermined dose when activated against the skin to ease the self-administration process.“For a chronic condition like gMG, having differe
  • Does a Designated Pharmacist Improve OPAT Outcomes?

    Does a Designated Pharmacist Improve OPAT Outcomes?
    By Meaghan Lee Callaghan and Landon GrayDoes including a designated pharmacist in managing outpatient parenteral antimicrobial therapy (OPAT) improve patient outcomes?A new study presented at MAD-ID x SIDP 2026 suggests yes, but more research is needed.Study authors Meg Parmalee, PharmD, a PGY-2 oncology pharmacy resident, and Tamanna Talwar, PharmD, a PGY-1 ambulatory pharmacy resident, both at UNC Health, in Chapel Hill, North Carolina, spoke with Infectious Disease Special Edition at the conf
  • AXS26 Panel: Keep Cybersecurity Top of Mind

    AXS26 Panel: Keep Cybersecurity Top of Mind
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksRansomware attacks that prevent e-prescribing and firewall breaches that provide a direct line to protected health information are among cybersecurity risks pharmacists face daily, whether operating independently, within a chain, or in a health system. Speakers at Asembia’s AXS26 Summit, in Las Vegas, stressed the importance of cybersecurity strategy.“As a pharmacist myself, I know how comple
  • Smart Pump–EHR Interoperability: Big Promise, Thin Evidence to Date

    Smart Pump–EHR Interoperability: Big Promise, Thin Evidence to Date
    By Marcus A. BanksConnecting smart infusion pumps directly to the electronic health record (EHR) has the potential to reduce medication errors, streamline nursing workflow, and improve charge capture, but the evidence supporting these gains is still immature, according to a recent systematic review (Intensive Crit Care Nurs 2026;97:104475).Interoperability allows a verified EHR order to auto-program the infusion pump and pump to auto-document the infusion back into the record, reducing manual ke
  • Building a CAR-T Bridge With Bispecifics for Lymphoma

    By Gina ShawBispecific antibodies (BiAbs) are achieving impressive results, in some cases more than doubling the survival gains seen with conventional chemotherapy. These advances are pushing oncology teams to reconsider whether these powerful anticancer drugs can be used earlier to carry more patients to potentially curative cellular therapy, speakers noted during a session at HOPA26, in New Orleans.Glofitamab-gxbm (Columvi, Genentech) is a case in point. When added to gemcitabine and oxaliplat
  • Ascension Error Exposes Gaps Hospitals Should Audit Now

    Ascension Error Exposes Gaps Hospitals Should Audit Now
    By Gina ShawPharmacy leaders should use the medication error that severely injured four joint replacement patients at Ascension Saint Thomas Hospital Midtown, in Nashville, Tennessee, as a prompt to examine their own sterile compounding safeguards—particularly barcode overrides, batch preparation, high-alert medication storage, technician competency assessment, and final pharmacist verification, medication safety experts said.The Tennessee Health Facilities Commission’s 80-page surve
  • SCCM Speakers: AI Tools Require Strong Governance and Rigorous Vetting

    Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksArtificial intelligence tools for clinical decision-making hold promise but may not be ready for everyday use, according to a discussion forum at the 2026 Critical Care Congress, in Chicago. Financial limitations may impede AI adoption as well.“The AI tools that are the most validated, as with sepsis detection, require institutional purchase before people can access them. Given financial constraint
  • SenderraRx Earns ACHC Reaccreditation in Specialty Pharmacy and Oncology Distinction

    Originally published by our sister publication Specialty Pharmacy ContinuumSenderra Specialty Pharmacy announced that it has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), including a Distinction in Oncology. Reaccreditation reflects an independent evaluation against nationally recognized standards for specialty pharmacy quality, safety, and patient care. The Oncology Distinction recognizes Senderra’s oncology-focused clinical oversig

Follow @newsl_pharmacy on Twitter!